|Published (Last):||9 October 2015|
|PDF File Size:||13.22 Mb|
|ePub File Size:||16.93 Mb|
|Price:||Free* [*Free Regsitration Required]|
Prognostic significance of serum lactate dehydrogenase in patients with osteosarcoma of the extremities. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions. Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy.
Synchronous multifocal osteosarcoma: Results in twelve patients treated with neoadjuvant chemotherapy and simultaneous resection of all involved bones. Scintigraphically negative skip metastasis in osteosarcoma. Campanacci M. Springfield: Charles C. Thomas; Damron TA.
Endoprosthetic replacement following limb-sparing resection for bone sarcoma. Diamandopoulas GT. Induction of lymphocytic leukemia, lymphosarcoma, reticulum cell sarcoma and osteogenic sarcoma in the Syrian golden hamster by oncogenic DNA simian virus Dorfman HD, Czerniak B.
Expandable endoprostheses reconstruction in skeletally immature patients with tumors. Expandable endoprosthetic reconstruction of the skeletally immature after malignant bone tumor resection. Enneking WF. A system of staging musculoskeletal neoplasms.
A system for the surgical staging of musculoskeletal sarcoma. Louis, , Mosby, pp Estrada J. Current treatment of osteosarcoma. Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Loss of heterozygosity of the Rb gene is a poor prognostic factor in patients with osteosarcoma. Virus induction of osteosarcomas in mice. Limb-salvage surgery in the treatment of osteosarcoma in skeletally immature individuals.
Fuchs B and Pritchard DJ. Etiology of osteosarcoma. Gibbs, Jr. Malignant bone tumors. J Clin Oncol ; The cost-effectiveness of limb salvage for bone tumours. The effect of adjuvant chemotherapy on osteoarticular allografts. P-glycoprotein levels predict poor outcome in patients with osteosarcoma. Correlation of c-fos, p53, and PCNA expression with treatment outcome in osteosarcoma. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma. Ladanyi M, Gorlick R. Molecular pathology and molecular pharmacology of osteosarcoma. Link MP. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study.
The effect of adjuvant chemotherapy on relapse-fee survival in patients with osteosarcoma of the extremity. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. The hazards of biopsy in patients with malignant primary bone and soft tissue tumors. The hazard of biopsy, revisited. Long-term results of allograft replacement in the management of bone tumors. Biology and therapeutic advances for pediatric osteosarcoma.
Improved prognosis of children with osteosarcoma metastatic to the lung s at the time of diagnosis. A familial loss of heterozygosity study. Rotationplasty as a reconstructive operation after tumor resection. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Osteogenic sarcoma with clinically detectable metastasis at initial presentation. Mirra JM. Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma. Use of a smooth press-fit stem preserves physeal growth after tumor resection. Early multicenter experience with a noninvasive expandable prosthesis. Parosteal osteosarcoma. A clinicopathological study. ERbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis. The co-expression of p53 protein and P-glycoprotein is correlated to a poor prognosis in osteosarcoma. Limb salvage with tumor endoprostheses for malignant tumors of the knee. Conventional osteosarcoma.
Comparison of quality of life after amputation or limb salvage. A filterable agent the cause of a second chicken-tumor, an osteochondrosarcoma. Complications and surgical indications in cases of nonmetastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy. The incidence and prognosis of osteosarcoma skip metastases. Conventional and dedifferentiated parosteal osteosarcoma. Diagnosis, treatment, and outcome. Development of resistance in mice to tumour induction by SE polyoma virus.
Magnetic resonance imaging of osteosarcoma. Growing endoprostheses for primary malignant bone tumors. Tucker MA. Risk factors for the occurrence of leukemia and bone sarcomas as second malignant tumors. Bone sarcoma linked to radiotherapy and chemotherapy in children.
Bone Cancer BC linked to radiotherapy and chemotherapy in children. Aseptic loosening in cemented custom-made prosthetic replacements for bone tumours of the lower limb. Endoprosthetic bone reconstruction following malignant tumor resection in skeletally immature patients. Weis L. Wuisman P, Enneking WF. Prognosis for patients who have osteosarcoma with skip metastasis.
MR imaging based strategies in limb salvage surgery for osteosarcoma of the distal femur. Widhe B, Widhe T. Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. Winkelmann WW. Atlas of Orthopaedic Pathology. Saunders Company; Dedifferentiated parosteal osteosarcoma. Relationship between vascular endothelial growth factor expression and angiogenesis in osteosarcoma.
Tratamiento del Osteosarcoma, complicaciones y pronóstico